AKT1 and colorectal carcinoma: Furthermore, ACY-1215 exerts its antitumor effect by the inhibition of proliferation and induction of apoptosis by inhibiting the MAPK/ERK and PI3K/AKT signaling pathways in CRC cell lines [19,168].